Otitis Externa

• Disruption of cerumen barrier and epithelial integrity: The external auditory canal is normally protected by cerumen (earwax), which is an emulsion of sebaceous and ceruminous gland secretions combined with shed epithelial cells. Cerumen provides antimicrobial protection through its acidic pH (6.5-8.5, typically acidic), lipid content (which inhibits bacterial adhesion), and immunoglobulin A (IgA) and lysozyme content. Water exposure, cotton swab trauma, hearing aids, or excessive cerumen removal disrupts this barrier. The canal epithelium is thin (0.5 mm) and lacks a subcutaneous fat layer, making it particularly vulnerable to irritation and infection. Moisture (from swimming, showering, or high humidity) maceration the epithelium, and the combination of epithelial breakdown plus moisture creates an ideal environment for bacterial overgrowth. Bacterial proteases and lipases degrade remaining lipid barriers and further damage epithelial tight junctions through release of inflammatory mediators.

• Pathogen colonization and biofilm formation: The normal external auditory canal flora includes Staphylococcus epidermidis, coagulase-negative staphylococci, and Corynebacterium species, which normally prevent pathogenic colonization through competitive inhibition and bacteriocin production. When epithelial integrity is compromised, pathogenic organisms—predominantly Pseudomonas aeruginosa and Staphylococcus aureus—colonize the canal epithelium. Pseudomonas species are particularly virulent in otitis externa because they preferentially thrive in moist environments, produce biofilms resistant to both antibiotics and host immunity, and secrete exotoxins (including exotoxin A and elastase) that directly destroy epithelial cells and penetrate tissue planes. These organisms establish biofilms where sessile cells upregulate efflux pump expression and downregulate porins, creating high-level antimicrobial resistance. The biofilm matrix itself protects bacteria from concentrations of antibiotics that would kill planktonic cells.

• Acute inflammatory cascade and tissue edema: Once pathogens establish infection, tissue invasion triggers innate immune responses through pattern recognition receptors (TLRs 2, 4, 5) on epithelial cells and infiltrating macrophages. This activates NF-κB signaling, leading to production of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-8. These cytokines increase vascular permeability through VE-cadherin disruption and endothelial gaps, leading to exudation of fluid and plasma proteins into interstitial spaces. The canal's rigid bony walls prevent outward expansion of this edema; therefore, increasing edema compresses the EAC lumen, restricting drainage and creating positive pressure within the canal. This mechanical compression, combined with mucosal inflammation and purulent exudate, generates severe pain through stimulation of trigeminal and vagal nociceptors. The intense pain (often out of proportion to objective findings) is the hallmark of acute otitis externa and results from this pressure effect combined with direct chemical irritation from bacterial toxins and inflammatory mediators.

• Disease progression and potential spread: In immunocompetent hosts with prompt treatment, inflammation remains localized to the canal epithelium and resolves without sequelae. However, in inadequately treated cases or immunocompromised patients (particularly those with diabetes, HIV, chemotherapy, or renal failure), Pseudomonas can invade the deeper tissues underlying the EAC epithelium. The canal epithelium normally adheres loosely to underlying periosteum, but tissue invasion leads to osteitis of the temporal bone. If invasion progresses through the tympanic plate or mastoid bone, the condition evolves into necrotizing (malignant) otitis externa, a potentially life-threatening infection discussed in the Complications section. The invading bacteria trigger osteoclast activation through RANKL upregulation, leading to progressive bone destruction. Concurrently, vascular granulation tissue fills defects and may eventually heal with fibrosis, sometimes resulting in canal stenosis if severe.

• Bacterial infection (85-90% of cases): Pseudomonas aeruginosa is the most common pathogen overall, responsible for 40-50% of cases, particularly in acute diffuse otitis externa. P. aeruginosa has a predilection for the warm, moist canal environment and is selected for by the microbiology of the canal. Staphylococcus aureus (including MRSA) accounts for 15-25% of cases, with higher prevalence in localized furunculosis of the canal or in patients with eczema. Staphylococcus epidermidis and other coagulase-negative staphylococci are less virulent pathogens. Less common organisms include Proteus, Klebsiella, Enterococcus, and anaerobes. Fungal infection with Aspergillus niger or Candida albicans accounts for only 5-10% of cases, typically in patients on prolonged topical antibiotics that suppress normal bacterial flora, or with immunosuppression. These fungi produce mycotoxins and can trigger allergic responses in addition to direct invasion.

• Water exposure: Swimming is the classic risk factor, where contaminated freshwater or chlorinated pools introduce pathogenic bacteria directly into the canal while simultaneously maceration the epithelium. Hot tubs and whirlpools have particularly high bacterial counts. Even showering or bathing with inadequate ear protection increases risk. This explains the marked seasonal increase in summer months and the term "swimmer's ear." The risk is further increased if the canal epithelium is already compromised by eczema, psoriasis, or prior canal trauma.

• Cerumen impaction and removal: Excessive cerumen removal—whether through aggressive cleaning, cotton swab use, or instrumentation during ear cleaning—removes the protective lipid barrier and damages the delicate epithelium, creating microabrasions. Paradoxically, cerumen impaction itself can trap moisture and promote bacterial overgrowth. The canal is exquisitely sensitive to mechanical trauma; even minor scratches from cotton swabs can initiate infection.

• Hearing aids and ear canal occlusion: Hearing aids create a sealed, moist microenvironment and cause chronic low-grade trauma to the canal wall. They reduce cerumen clearance by blocking the normal canal self-cleaning mechanism. Chronic hearing aid use is a major risk factor for recurrent otitis externa, particularly in elderly patients.

• Dermatologic conditions: Atopic dermatitis, seborrheic dermatitis, and psoriasis affect canal epithelium, creating chronic inflammation and barrier dysfunction. Eczematous changes predispose to secondary bacterial or fungal infection. Patients with these conditions often require preventive strategies.

• Immunocompromise: Diabetes mellitus (particularly with poor glycemic control), HIV infection with low CD4 counts, chemotherapy, organ transplantation, and chronic corticosteroid use impair neutrophil function and T-cell immunity. These patients are at dramatically increased risk for progression to necrotizing otitis externa and require more aggressive treatment thresholds.

• Environmental factors: High humidity, heat, and perspiration favor Pseudomonas proliferation. Chlorinated water exposure, salt water, and contaminated water sources increase inoculum. Trauma from foreign bodies, aggressive instrumentation, or insertion of non-sterile objects dramatically increases infection risk.

• Allergic and inflammatory causes: Primary allergic otitis externa, contact dermatitis from topical medications or solutions, and reactions to hearing aid materials can cause channel inflammation and secondary infection.

• Otalgia (ear pain): This is the cardinal symptom and is often described as severe, throbbing, or deep-seated, and markedly disproportionate to objective findings—a classic clinical pearl that often leads to initial misdiagnosis as otitis media. Pain typically worsens dramatically with manipulation of the auricle (the "tragal sign") or pressure on the canal entrance, a physical exam maneuver useful for diagnostic confirmation. The pain mechanism stems from the rigid canal anatomy creating pressure from inflammatory edema, combined with direct chemical irritation from bacterial toxins and inflammatory mediators activating trigeminal nociceptors. Pain often awakens patients from sleep and may be severe enough to interfere with sleep and eating.

• Otorrhea (ear drainage): Purulent, mucopurulent, or sanguineous drainage from the canal indicates active infection with bacterial colonization and tissue breakdown. The drainage may have a foul odor, particularly in cases with anaerobic superinfection or fungal involvement. Otorrhea indicates progression beyond simple canal edema to actual epithelial breakdown and exudation.

• Hearing loss and aural fullness: Partial conductive hearing loss results from canal edema narrowing the EAC lumen and impeding sound transmission, or from accumulated cerumen and purulent exudate within the canal. Patients may report aural fullness, a sensation of "water in the ear," or low-frequency hearing reduction. This typically resolves with successful treatment but is another distinguishing feature from otitis media (where pain is typically less severe and hearing loss, if present, affects higher frequencies).

• Pruritus (itching): Mild itching or irritation may precede pain in early or localized infection, particularly in allergic or eczematous otitis externa. However, severe pain typically dominates the symptom complex.

• Systemic symptoms: In uncomplicated acute otitis externa in immunocompetent hosts, systemic symptoms are typically absent. Fever, malaise, lymphadenopathy, or systemic toxicity should raise suspicion for progression to necrotizing otitis externa or concurrent systemic infection, particularly in immunocompromised patients.

• Physical examination findings—external ear and canal: Otoscopic examination reveals erythema and edema of the canal epithelium, which may appear bright red, swollen, and granular. In early cases, findings may be limited to mild canal erythema. As infection progresses, edema becomes more pronounced, the canal lumen narrows (sometimes occluding visualization of the tympanic membrane), and purulent exudate accumulates. The tympanic membrane should normally be visible and intact; if it cannot be visualized due to canal swelling, clearing the canal (by careful removal of exudate) is necessary to rule out concurrent otitis media. The auricle may show erythema, swelling, or involvement of surrounding skin in severe cases. Tragal tenderness or pain with manipulation of the auricle (tragal sign) is highly specific for otitis externa. Palpation of the mastoid process and periauricular nodes is typically non-tender (contrasting with mastoiditis), though regional lymphadenopathy may occur.

• Localized furunculosis variant: Some cases present with a localized, raised, pustular lesion on the lateral canal wall or auricle, typically caused by Staphylococcus aureus. These furuncles are extremely painful and may have a visible purulent center or pointing. This presentation is sometimes called "acute circumscribed otitis externa" and may respond to local measures or incision and drainage earlier than diffuse otitis externa.

• Chronic otitis externa: Prolonged or recurrent cases show chronic inflammation with canal epithelial thickening, fibrosis, and sometimes formation of granulation tissue. The canal may become edematous even with minor provocation and is prone to recurrent infection.

• Clinical diagnosis and diagnostic criteria: The diagnosis of otitis externa requires both canal epithelial inflammation (erythema, edema, or exudate) visible on otoscopy AND symptoms or signs of canal infection/inflammation. Most commonly, this includes otalgia with tragal tenderness or canal edema. The diagnostic challenge is distinguishing otitis externa from otitis media (see differential diagnosis). Diagnostic criteria typically require at least two of the following: (1) rapid onset (within 48 hours), (2) tragal or canal tenderness, (3) canal edema, erythema, or exudate, or (4) otorrhea. Pain that is severe and disproportionate to findings, worsened by tragal pressure, and not associated with upper respiratory infection symptoms all favor otitis externa over otitis media.

• Differential diagnosis from otitis media: This is the most common clinical error. Otitis media presents with pain that is often less severe than otitis externa, may follow upper respiratory infection, and is confirmed by findings of tympanic membrane inflammation (erythema, bulging, fluid level, or air-fluid levels). The tympanic membrane should be normal in otitis externa—if it cannot be adequately visualized due to canal debris, clearing the canal is essential. Tragal tenderness favors otitis externa. Otitis media may present with fever and systemic symptoms more commonly than otitis externa. Audiometry in otitis media typically shows a conductive hearing loss pattern consistent with middle ear effusion, whereas in otitis externa, hearing loss is from mechanical obstruction of the canal lumen by edema/exudate.

• Otoscopic examination pearls: The external auditory canal should be gently examined with appropriately sized specula; speculum size should fill the canal without being forcefully inserted (instrumentation can cause trauma and worsen inflammation). In very edematous canals, visualization of the tympanic membrane may be impossible without gentle removal of exudate using a curette or irrigation with warmed normal saline. The examiner must be cautious not to further traumatize the inflamed epithelium. If canal edema is so severe that the tympanic membrane cannot be visualized even after gentle cleaning, this finding alone is consistent with otitis externa and does not mandate further imaging. Look for the specific location of erythema (circumscribed vs. diffuse), character of any exudate (purulent, sanguineous, or fungal-appearing), and the degree of canal narrowing.

• Cultures and sensitivities: Cultures are not indicated for routine uncomplicated otitis externa in immunocompetent hosts and do not change management—all cases are initially treated empirically with topical antimicrobials covering the most likely pathogens. Cultures ARE indicated in the following scenarios: (1) immunocompromised patients suspected of necrotizing otitis externa (to guide IV antibiotic therapy), (2) severe infections unresponsive to standard topical therapy after 1-2 weeks of treatment (suggesting resistant organisms), (3) fungal otitis externa suspected (to confirm organism and guide antifungal selection), (4) recurrent otitis externa in the same ear, and (5) healthcare-associated infections (heightened suspicion for resistant Gram-negatives or Pseudomonas). Specimens should be obtained by careful swab of exudate or epithelial debris; care must be taken to avoid contamination with speculum material or external canal bacteria.

• Audiometry: Formal audiometry is not routinely needed for diagnosis but may be useful in cases with significant hearing loss or suspected complications involving middle ear structures. Conductive hearing loss consistent with canal obstruction supports the diagnosis of otitis externa.

• Imaging and advanced diagnostic modalities: Plain radiographs are not indicated in uncomplicated otitis externa. High-resolution CT (HRCT) of the temporal bone is essential when necrotizing otitis externa is suspected, as it reveals bone invasion, osteitis of the mastoid and tympanic plate, and potentially intracranial spread. CT shows areas of bone destruction (lytic lesions), cortical breakthrough, and soft tissue inflammation. MRI with gadolinium may show soft tissue involvement more sensitively and is useful when intracranial

Initial steps at the visit

• Assess tympanic membrane integrity first: the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) Clinical Practice Guideline: Acute Otitis Externa makes this the pivotal branch point, because a perforation or tympanostomy tube allows middle-ear entry of ototoxic agents.
• Analgesia: acetaminophen or an NSAID for mild–moderate pain; canal pressure from non-expandable edema makes the pain severe, and the AAO-HNSF guideline explicitly requires pain to be assessed and treated. Reserve short-course opioids for severe pain.
• Aural toilet: gentle removal of debris and desquamated epithelium under direct visualization improves drop delivery, since biofilm and exudate block topical penetration.

First-line therapy (uncomplicated diffuse AOE)

• Topical antimicrobial drops, not systemic antibiotics: topical delivery achieves canal concentrations orders of magnitude above MIC. Representative agents include a fluoroquinolone otic (ofloxacin, or ciprofloxacin–dexamethasone), an aminoglycoside-containing combination (neomycin–polymyxin B–hydrocortisone), or an acidifying/antiseptic agent (acetic acid), typically for about a week. No topical regimen is clearly superior in the AAO-HNSF guideline.
• Added topical glucocorticoid speeds resolution of edema and pain by suppressing the cytokine-driven capillary leak described above.
• Ear wick: if canal edema occludes the lumen, place a compressed cellulose/gauze wick so drops reach the medial canal.
• Water precautions and avoidance of cotton swabs until healed; recheck in roughly 48–72 hours if not improving.

Escalation and special situations

• Systemic antipseudomonal therapy (oral ciprofloxacin) only when infection extends beyond the canal (cellulitis of the pinna/face), or in poorly controlled diabetes or immunocompromise.
• Otomycosis: topical antifungal (clotrimazole) after thorough cleaning; stop antibacterial drops.
• Furunculosis: anti-staphylococcal coverage and incision/drainage of a pointing lesion.
• Necrotizing (malignant) otitis externa: admit, obtain deep culture and temporal bone CT, and give prolonged IV antipseudomonal therapy (ciprofloxacin, or an antipseudomonal beta-lactam such as ceftazidime, cefepime, or piperacillin–tazobactam) with strict glycemic control; surgery is limited to debridement of necrotic tissue/abscess, not cure.

Contraindicated

• Aminoglycoside or low-pH drops with a non-intact tympanic membrane — cochleovestibular ototoxicity; use a non-ototoxic fluoroquinolone otic instead.
• Routine oral antibiotics for uncomplicated AOE — no benefit, drives resistance and adverse effects.

Emergency complications

• Necrotizing (malignant) otitis externa: Pseudomonas invades from canal epithelium through the fissures of Santorini into the temporal bone, producing skull base osteomyelitis. Signal findings are granulation tissue at the bone–cartilage junction of the canal floor in an elderly diabetic or immunocompromised patient, deep boring otalgia out of proportion and worse at night, and a markedly elevated ESR/CRP. This is a hospital-admission emergency: CT of the temporal bone for bone erosion, deep culture, and IV antipseudomonal therapy.
• Cranial neuropathies: extension to the stylomastoid foramen causes facial nerve (CN VII) palsy, the most common and an ominous sign of advanced disease; jugular foramen spread affects CN IX, X, and XI; petrous apex spread can affect CN VI. Any new cranial nerve deficit signals progression and mandates urgent imaging.
• Intracranial extension: meningitis, sigmoid or cavernous sinus thrombosis, epidural/brain abscess. Fever with headache, meningismus, or altered mental status is an emergency requiring contrast MRI/MRV and neurosurgical/ID involvement.

Local complications

• Periauricular cellulitis and perichondritis/chondritis: spread to auricular cartilage, which is avascular and prone to necrosis; the pinna is diffusely erythematous and tender with sparing of the lobule (no cartilage there). Untreated chondritis produces cauliflower ear.
• Canal stenosis and chronic otitis externa: repeated inflammation heals by fibrosis, narrowing the lumen and causing persistent conductive hearing loss and recurrent infection.
• Myringitis or secondary otitis media if the tympanic membrane becomes involved or perforates.

Treatment-related complications

• Contact dermatitis from neomycin: a classic delayed (type IV) hypersensitivity; suspect it when the canal and pinna become more erythematous, weepy, and pruritic after several days of drops — the common trap of mistaking it for treatment failure.
• Ototoxicity: aminoglycoside drops crossing a perforation cause sensorineural hearing loss and vertigo.
• Otomycosis: prolonged antibacterial drops eliminate competing flora, permitting Aspergillus niger overgrowth — black/white fungal debris resembling wet newspaper with itching more than pain.

• Pain on tragal pressure or pinna traction with a normal tympanic membrane is the discriminator from acute otitis media. If the drum looks normal and the tragus hurts, it is otitis externa.
• ***Swimmer's ear* = Pseudomonas aeruginosa***: the single most tested association. Staphylococcus aureus causes the localized furuncle variant; Aspergillus niger causes otomycosis after prolonged antibiotic drops.
• Best next step in uncomplicated disease is topical drops, not oral antibiotics: the AAO-HNSF guideline recommends topical therapy alone. Choosing oral amoxicillin or cephalexin is the classic distractor.
• Always ask whether the tympanic membrane is intact before choosing a drop: with a perforation or tube, pick a fluoroquinolone otic (ofloxacin) and avoid aminoglycoside or acidifying drops because of ototoxicity.
• If the canal is swollen shut, place an ear wick — the drops cannot reach the medial canal otherwise, and "treatment failure" on a stem is often just failed delivery.
• Elderly diabetic + severe nocturnal otalgia + granulation tissue on the canal floor at the bone–cartilage junction = necrotizing (malignant) otitis externa. Next step: temporal bone CT and IV antipseudomonal therapy; facial nerve palsy is the ominous sign. ESR is characteristically very high and is used to follow response.
• Worsening erythema, itching, and weeping after several days of neomycin-containing drops is contact dermatitis, not resistant infection — stop the drug rather than escalate.
• Auricular erythema and tenderness that spares the lobule points to perichondritis of cartilage, a cosmetic emergency that needs antipseudomonal coverage.
• Do not order imaging for routine otitis externa; a canal too edematous to visualize the drum is expected, not an indication for CT.